Healthcare
Copywriting &
Lead Generation
For pharma, medtech, health tech, and clinical research companies who need copy that's persuasive without ever crossing a compliance line.
For pharma, medtech, health tech, and clinical research companies who need copy that's persuasive without ever crossing a compliance line.
I am a pharmacist, currently pursuing an MSc of Pharmacoeconomics. I write content and build outbound systems for healthcare, health-tech, and life sciences companies. Right now, I'm running the outbound engine and writing recruitment copy for a patient recruitment platform (PRO) from Los Angeles, working with Sponsors, CROs, and research sites across the US.
Outside of copy, I track pharma industry news daily on Daily Pharma-Industry, a Threads channel covering drug manufacturing, supply chains, and market shifts.
Most copywriters treat healthcare like any other niche. Most lead gen specialists treat every buyer in a healthcare niche the same way.
Both mistakes show up fast: content that's either too salesy or too clinical, outreach that gets the persona wrong, campaigns that never quite land with an audience that's more skeptical and better informed than most.
I come at it from the other direction. The difference between a Clinical Ops buyer and a Marketing Director, or between content that needs to be medically precise and content that just needs to convert, isn't theory to me. It's what I navigate every day.
Most healthcare copy either overclaims or plays it too safe, because the writer doesn't actually know where the compliance line sits for that category. A supplement claim, an Rx drug ad, and a trial recruitment email all answer to different rules, and treating them the same is how copy gets flagged, rewritten, or ignored.
Every project starts with the category, not a template. What can legally be claimed here? Who actually reads this: a VP, a patient, a caregiver, a regulator? About 70% of the effort is research, understanding the product, the audience, and the real pressures they're under, before a single line gets written.
Step 01, in detail
Step 02, in detail
Self-initiated case study, not affiliated with Antidote or Roche.
Antidote is past the "we have AI matching" pitch, since every vendor says that now. The real differentiation is in the mechanism behind the match, not the match itself.
Built the full funnel around one idea: the validation layer, not the algorithm, protects a trial's cohort. Cold email, LinkedIn, patient ads, landing page, and nurture emails all carry the same mechanism, in different voices for different readers.
Why does a PRO or site need an outbound engine? As of August 2026, email marketing is still one of the most effective marketing channels, with an ROI of roughly 3,600–4,200%, that's $36 to $42 in revenue for every $1 spent.
In B2B outbound specifically, the role of this channel is even more evident. A well-run email engine can secure introductory calls for the business, serving as the starting point for a major contract.
Source: industry-wide email marketing ROI benchmarks (Litmus, DMA, Omnisend), 2026. Figure reflects email marketing broadly, not cold B2B outreach specifically.9 days from launch to first call, for a PRO sponsor in Los Angeles
"Thanks for getting back to our team. Emily Johnson shared your contact information with me, and I'm helping with the recruitment efforts for our Phase 2 ADP Vista study. We'd love to learn more about WeHealth's services and capabilities and discuss our recruitment needs... Looking forward to connecting!"
Based on open-rate and click-through data since, this pilot is projected to generate at least two or three additional introductory calls, as the metrics indicate the engine is performing effectively. All collected data is analyzed in real time to optimize the pilot. For instance, leads who open an email multiple times without replying are approached with a different strategy than leads who don't open it at all.
